Feature Channels:

Blood

Add to Favorites Subscribe Share
fbshare-Blood

Showing results

110 of 1361
image001.png

Blood transfusions: Fresh red blood cells no better than older ones.

Universite de Montreal

Findings from the ABC-PICU study on critically ill children may alter policies at hospitals where fresh red cells are preferentially used.

Channels: All Journal News, Blood, Children's Health, National Heart, Lung, and Blood Institute (NHLBI), JAMA,

Released:
10-Dec-2019 1:00 PM EST
Newswise: Yale Cancer Center researchers investigate inducing “synthetic lethality” in two blood and bone cancers

Yale Cancer Center researchers investigate inducing “synthetic lethality” in two blood and bone cancers

Yale Cancer Center

In a clinical trial led by Yale Cancer Center (YCC) and Smilow Cancer Hospital, researchers aim to exploit DNA mutations in the treatment of two blood and bone marrow cancers, a different tacit than the more traditional approach of blunting or switching off genetic mutations linked to cancer

Channels: All Journal News, Blood, Cancer, Genetics, Healthcare, Medical Meetings,

Released:
10-Dec-2019 10:55 AM EST
Research Results
Newswise: ASH: Research revises classification of acute myeloid leukemia and myelodysplastic syndrome

ASH: Research revises classification of acute myeloid leukemia and myelodysplastic syndrome

St. Jude Children's Research Hospital

Results from a study conducted by St. Jude Children’s Research Hospital and the Munich Leukemia Laboratory were presented today as a late-breaking abstract at the American Society of Hematology annual meeting. The study integrates genomic and transcriptomic sequencing to provide the most detailed classification of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) to date.

Channels: Blood, Cancer, Cell Biology, Medical Meetings,

Released:
10-Dec-2019 8:15 AM EST
Research Results
mmc-logo.gif
  • Embargo expired:
    9-Dec-2019 6:00 PM EST

New Mayo Clinic studies to be presented at American Society of Hematology meeting

Mayo Clinic

Mayo Clinic researchers will present findings at the American Society of Hematology Annual Meeting Dec. 7–10 in Orlando. New Mayo Clinic studies to be presented include: DNA analysis identifies elevated risk factor for myeloma in individuals of African ancestry Study identifies more precise assessment measures for patients newly diagnosed with chronic lymphocytic leukemia Researchers develop method to assess cancer-fighting cell therapy's effectiveness

Channels: All Journal News, Blood, Cancer, Stem Cells, Medical Meetings,

Released:
6-Dec-2019 10:10 AM EST
Research Results
Newswise: Small Mutations Identified through Deep DNA Sequencing for AML and MDS

Small Mutations Identified through Deep DNA Sequencing for AML and MDS

Rutgers Cancer Institute of New Jersey

Deep DNA sequencing analysis conducted by Rutgers Cancer Institute of New Jersey investigators examining genomic differences within tumors for prediction of disease relapse in certain hematologic malignancies has identified small mutations. These may help further guide treatment decision making for patients.

Channels: All Journal News, Blood, Cancer, Genetics, Medical Meetings,

Released:
9-Dec-2019 5:05 PM EST
Research Results
Newswise: Yale Cancer Center study suggests new approaches needed to manage ibrutinib-related toxicities in CLL patients
  • Embargo expired:
    9-Dec-2019 3:45 PM EST

Yale Cancer Center study suggests new approaches needed to manage ibrutinib-related toxicities in CLL patients

Yale Cancer Center

New findings by Yale Cancer Center (YCC) and Smilow Cancer Hospital researchers show that as the use of the drug ibrutinib climbs in patients with chronic lymphocytic leukemia (CLL), so do the rates of patients who stop taking the drug.

Channels: All Journal News, Blood, Cancer, Clinical Trials, Pharmaceuticals, Medical Meetings,

Released:
9-Dec-2019 10:50 AM EST
Research Results
Newswise: CAR T-cell therapy effective for relapsed mantle cell lymphoma patients
  • Embargo expired:
    9-Dec-2019 2:45 PM EST

CAR T-cell therapy effective for relapsed mantle cell lymphoma patients

University of Texas M. D. Anderson Cancer Center

A one-year follow-up study revealed a majority of patients with mantle cell lymphoma resistant to prior therapies may benefit from treatment with CD19-targeting chimeric antigen receptor (CAR) .

Channels: All Journal News, Blood, Cancer, Healthcare, Pharmaceuticals,

Released:
4-Dec-2019 12:40 PM EST
Research Results
Newswise: Yale Cancer Center researchers show promising new treatment for patients with myelodysplastic syndromes

Yale Cancer Center researchers show promising new treatment for patients with myelodysplastic syndromes

Yale Cancer Center

A new study by Yale Cancer Center (YCC) and Smilow Cancer Hospital researchers suggests that the drug venetoclax aids therapy for relapsed/refractory myelodysplastic syndromes, especially when paired with azacytidine.

Channels: All Journal News, Blood, Cancer, Pharmaceuticals, Healthcare, Medical Meetings,

Released:
9-Dec-2019 11:05 AM EST
Research Results
Newswise: Combination therapy more effective than chemotherapy alone for many newly diagnosed leukemia patients
  • Embargo expired:
    9-Dec-2019 10:30 AM EST
Released:
4-Dec-2019 12:30 PM EST
Research Results
Newswise: Dana-Farber scientists present promising findings in multiple myeloma at ASH Annual Meeting
  • Embargo expired:
    9-Dec-2019 7:45 AM EST

Dana-Farber scientists present promising findings in multiple myeloma at ASH Annual Meeting

Dana-Farber Cancer Institute

Results of studies on a novel agent to treat multiple myeloma and a combination therapy aimed at slowing the progression of a precursor myeloma condition are among reports being presented by Dana-Farber Cancer Institute investigators at the ASH Annual Meeting.

Channels: Blood, Cancer, Cell Biology, Medical Meetings,

Released:
6-Dec-2019 8:30 AM EST
Research Results

Showing results

110 of 1361

Chat now!
8.37467